From Research to Practice

Clinical and Translational Nutrition

Panel Discussion / Questions and Answers - Meeting the Nutritional Needs of Patients on Anti-Obesity Medications: What’s New?

Chair(s)

• 

  Christos S. Katsanos, PhD (he/him/his)

  Associate Professor
  Arizona State University
  Phoenix, Arizona, United States

  Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

• 

  Jaime Almandoz, MD, MBA, MRCPI, FTOS (he/him/his)

  Medical Director, Weight Wellness Program; Associate Professor of Internal Medicine; Division of Endocrinology
  UT Southwestern Medical Center
  Dallas, Texas, United States

  Disclosure(s): ABBVIE: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Eli Lilly: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Nestlé: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  Novo Nordisk: Advisory Committee/Board Member (Ongoing); Consultant (Ongoing)
  WAVE LIFE SCIENCES: Advisory Committee/Board Member (Terminated); Consultant (Terminated)
• 

  Jamy D. Ard, MD (he/him/his)

  Professor, Epidemiology & Prevention
  Wake Forest School of Medicine, Department of Epidemiology and Prevention
  Winston Salem, North Carolina, United States

  Disclosure(s): Amgen: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Boehringer Ingelheim: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Epitomee: Grant/Research Support (Terminated)
  Nestle Healthcare Nutrition: Consultant (Ongoing)
  Novo Nordisk: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Regeneron: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Weight Watchers: Consultant (Ongoing); Grant/Research Support (Ongoing)
  Zealand Pharma: Consultant (Ongoing)